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Abstract
Background: Health systems are not considered to be significantly influenced by European Union (EU) policies
given the subsidiarity principle. Yet, recent developments including the patients’ rights and cross-border directive
(2011/24 EU), as well as measures taken following the financial crisis, appear to be increasing the EU’s influence on
health systems. The aim of this study is to explore how health system Europeanisation is perceived by domestic
stakeholders within a small state.
Methods: A qualitative study was conducted in the Maltese health system using 33 semi-structured interviews.
Inductive analysis was carried out with codes and themes being generated from the data.
Results: EU membership brought significant public health reforms, transformation in the regulation of medicines
and development of specialised training for doctors. Health services financing and delivery were primarily unaffected.
Stakeholders positively perceived improvements to the policy-making process, networking opportunities and capacity
building as important benefits. However, the administrative burden and the EU’s tendency to adopt a ‘one size fits all’
approach posed considerable challenges. The lack of power and visibility for health policy at the EU level is a major
disappointment. A strong desire exists for the EU to exercise a more effective role in ensuring access to affordable
medicines and preventing non-communicable diseases. However, the EU’s interference with core health system values
is strongly resisted.
Conclusions: Overall domestic stakeholders have a positive outlook regarding their health system Europeanisation
experience. Whilst welcoming further policy developments at the EU level, they believe that improved consideration
must be given to the specificities of small health systems.
Keywords: Health policy, Health system reforms, European Union, Europeanisation, Qualitative study, Small states,
Malta
Background
The European Union (EU) acquired a health mandate in
1992 through the Maastricht Treaty, which is enshrined
in Article 168 of the Treaty on the Functioning of the
European Union (TFEU) [1]. This article must be read
in conjunction with articles 3, 4 and 5 of the TFEU,
which defines the competencies of the EU and the Member
States as well as the so-called ‘mixed competences’. The
essence of these Treaty provisions is that heath remains a
Member State competence and Union action can only
complement national policies but not supplant them.
Therefore, in accordance with the principle of subsidiarity,
the Union acts only insofar as the objectives of the pro-
posed action cannot be sufficiently achieved by the Member
States. Hence, the responsibility for organising and finan-
cing health systems remains a Member State responsibility
in accordance with the principle of subsidiarity [2, 3]. Of
course, this position leads to some ambiguity, which is also
reflected in the mixed outcomes of European health policy
[4, 5]. European level stakeholders perceive the results of
the EU health policy as a mixture of achievements, failures
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and missed opportunities [6]. Whereas the EU has become
a recognised player in the health sector, the extent to which
it has actually made a difference to the health of European
citizens is debated [7–9]. The EU has been described as
exerting its influence on health systems through three main
strands of activity: public health, market regulation and the
European Semester [10, 11]. This situation has led to pri-
marily ‘uninvited’ Europeanisation of health systems often
resisted by domestic stakeholders [12]. The effects of aus-
terity policies with the concomitant reduction in health
budgets [13], particularly in Greece and Spain, have tended
to generate a negative perception of EU action with regard
to health systems [14–16]. An analysis of Country Specific
Recommendations (CSRs) found that the European
Semester1 system of fiscal and economic governance
emphasises the financial sustainability of health sys-
tems over quality and accessibility [17]. Early analysis
of the implementation of the patients’ rights and cross
border care directive indicates the variable effects on
Member State health systems [18–23]. These develop-
ments point to an increasingly important role for the
EU in influencing health systems. In contrast, the Mission
Letter issued by Juncker to the health commissioner in
2014 sends a clear message that the policy on health sys-
tems is best left to individual Member States [24]. There-
fore, the future role of the EU regarding health systems
appears unclear at this point, with either role expansion or
retrenchment being possible outcomes.
The concept of Europeanisation has developed over
time and has been largely defined as an outcome or a
process [25].2 This paper adopts Radaelli’s definition of
Europeanisation as ‘a series of top-down and bottom-up
processes affecting both formal and informal rules as well
as procedures, policy paradigms, styles and shared beliefs
and norms’ [26]. This definition was selected because it
includes policy instruments other than legislation and,
therefore, is suitable for an assessment of health system
Europeanisation considering that EU action in this pol-
icy area is often pursued through instruments other than
legislation [27]. An examination of the domestic impact
of the EU on the Maltese health system can be classified
using the four types of outcomes that were described in
the Europeanisation literature [28], namely: inertia, or
Europeanisation occurring involuntarily if at all; retrench-
ment, or the continual resistance of EU pressures; adapta-
tion, or making certain changes that do not affect the
fundamentals of the system; and engaging in transforma-
tions that change the foundations of the domestic system,
leading to paradigm shifts. The ‘goodness of fit’ hypothesis
[29], although discredited as being too mechanistic and
lacking empirical evidence in certain respects [25, 30],
can still be usefully applied to an analysis of the
Europeanisation of the Maltese health system. One ex-
pects that a high degree of misfit leads to transformation
if domestic actors see value in adopting the European
policy and actively utilizing the EU requirements as lever-
age to bring about change. Retrenchment or inertia would
result where a conflict in values exists or the price tag
associated with change is perceived to be too high from a
domestic perspective. Adaptation or accommodation is
likely to occur in situations where the degree of misfit
is not unbearably high. Additionally, the literature on
Europeanisation emphasises the importance of networks
of elite stakeholders as mediating factors [31–33] in deter-
mining the overall effects of the EU on individual Member
States. An investigation of domestic stakeholders’ view-
points regarding the impact of the EU on their health
system can be important in furthering our understanding
of the manner in which the Europeanisation of health
systems occurs. In addition, obtaining an understanding of
domestic stakeholder expectations regarding the role that
should be played by the EU in health systems can inform
the manner in which health system Europeanisation oc-
curs in the future.
Malta, which joined the EU in 2004, was selected as
the setting for this study. An overview of the main fea-
tures of the Maltese health system is provided in Table 1.
Malta exhibits a relatively high level of engagement with
the EU, as exemplified by the country’s positive track
record in implementing legislation [34]. Malta is the
smallest EU Member State and has no internal regional
structures. A review of the effects of EU membership
after a decade [35] carried out at the national level found
that several sectors had been transformed, but also that
the health sector does not receive any particular men-
tion, which is consistent with the view that the health
sector should be considered as a case of ‘least likely’
Europeanisation [33]. An examination of the impact of
EU membership on the public service found that areas
significantly affected by EU policy, such as customs and
rural development, underwent significant policy change
accompanied by structural and procedural reform. Areas
less influenced by EU policy underwent little change.
Table 1 Key facts about the Maltese health care system
Malta acceded to the EU in 2004. It is the smallest Member State in
the EU with a population of 417,432 and a total land area of 315 km2.
The publicly funded health care system is the key provider of health
services. The private sector complements provision particularly in the
area of primary care and ambulatory specialist care. The Ministry is
responsible for setting policy and standards, for regulation of public
and private health services as well as for funding and direct organisation
and delivery of health care. The public health system is funded by general
tax revenues. Total health expenditure was 8.7 % of Malta’s GDP in 2012
of which public spending was only 5.6 %. Sustainability of the health
system has become identified as a key challenge and the Maltese health
system has come under the scrutiny during the European Semester
process. In 2013 and 2014 Malta has received Country Specific
Recommendations (CSRs) calling for a comprehensive reform of the
health system to improve the efficiency and sustainable use of
available resources.
Reproduced with permission from: [23]
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Following EU accession, two distinct types of public ad-
ministration can be identified in Malta, namely that which
is involved in EU policy and that which is unaffected by
EU policy. That EU membership was a strong driver of
public service change was concluded [34].
Studies on the Europeanisation of health care were iden-
tified for cross-border mobility [36–38], health care cover-
age [39], alcohol policy [40], communicable disease policy
[41, 42] and cancer [43]. However, to date no empirical
studies were found that investigated the attitudes of domes-
tic stakeholders towards health system Europeanisation.
In this paper, we apply the theory from European studies
to explore the effect of the EU on health systems as experi-
enced by domestic actors in the small EU Member State of
Malta. Specifically, we assess how EU membership affected
the Maltese health system. We also explore the attitudes of
domestic health system stakeholders to the EU and seek
their views on the future role they envisage for the EU with
respect to health systems. We seek to fill an identified gap
in the literature by going beyond an analysis of the manner
in which the EU has influenced the Maltese health system
and attempt to shed light on the normative dimension of
health system Europeanisation [44].
Methods
Design
This qualitative study used information collected from
face-to-face interviews to assess participants’ perceptions
of the development of the Maltese health system within
a European context. Permission to conduct this study was
obtained from the University Research Ethics Committee
at the University of Malta. The reporting of the study
closely followed the COREQ criteria [45].
Study participants and setting
Participants were recruited purposely with the principal
inclusion criterion being the role they held in the health
system or in European affairs over several years, such
that they were already involved at the time of Malta’s acces-
sion to the European Union. Thereafter, they remained
closely involved in decision making at the Malta–EU inter-
face for a certain period. Therefore, the sample included se-
nior public officers from the Ministries of Health and
European Affairs, politicians, senior clinicians and leaders
of civil society (Table 2). Thirty-five suitable participants
were invited by the principal investigator and informed
about the study. The voluntary nature of their partici-
pation was emphasised and precautions were taken to
safeguard anonymity. Two persons declined to partici-
pate, citing lack of sufficient knowledge of the subject.
Written informed consent was obtained from all partic-
ipants before the start of every interview. All interviews
were carried out only by the principal investigator and
in English.3 Interviews were face-to-face in a location
selected by the interviewee. Participants were informed
that, through each interviewee’s personal unique experi-
ence, the scope of the interview was to contribute towards
the construction of knowledge of how the Maltese health
system was affected by EU membership. The interviews
were audio recorded and transcribed verbatim.
Interview guide
A semi-structured interview guide was developed from
the literature on Europeanisation and small states and
was reviewed by experts in public health, European studies
and small state studies. Using this semi-structured inter-
view approach ensured a fixed core of themes and allowed
sufficient flexibility to digress and explore themes that
emerged during the interviews. The themes in the interview
included the following: participants’ experiences and views
on the health policy-making process in Malta, examples of
areas that changed as a result of EU membership, conse-
quences for the health system associated with EU member-
ship, the balance of competence between European and
national policy making in the health sector, institutions and
mechanisms through which the EU influences the health
system and reflections on Malta’s size and implications for
the policy-making process at the national and European
levels. Further probing was carried out using supplementary
questions primarily tailored to the background of the indi-
vidual interviewee.
Data analysis
An inductive approach was used to carry out the data
analysis. Nvivo® 10 was used to support the coding process.
To strengthen the validity of the data, the first five in-
terviews were coded by three researchers to establish
coherence and consistency. Subsequently, the remaining in-
terviews were each coded by two researchers. The coding
team consisted of the principal investigator and two re-
searchers from Maastricht University distant to the Maltese
health system. Additional codes were continuously added
throughout the remainder of the analysis to preserve the
richness of the data, bearing in mind that different stake-
holders often emerged with unique perspectives. The list of
Table 2 Professional roles of participants interviewed
Role Number of participants
European affairs public officer 4
Ministry of Health (MoH) public officer 13
Politician 5
Academic 3
Clinician 3
Civil society 5
Total 33
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codes that emerged was used to generate saturated clusters,
categories and broader dimensions and themes.
Researchers compared their interpretation of the codes
and divergences were discussed until consensus was
achieved. The codes were grouped into categories from
which key themes were identified. When determining
the labelling of the codes and the categories, care was
taken to preserve the original verbatim extracts of the
study’s participants to ensure that their ‘voices’ remained
visible throughout the research process [46]. Because the
study aimed to highlight the normative dimension of the
Europeanisation of the health system, this technique en-
hanced the authenticity of the data. Care was taken to
emphasise the main points of consensus and conver-
gence amongst the interviewees whilst also highlighting
deviant views and unique contributions—where appro-
priate—to reflect the complexity that emerged from the
stakeholder contributions [47].
Results
Thirty-three in-depth interviews were conducted with do-
mestic actors during July and August 2014. The interviews
were approximately 45 min and the total interviewing time
was 23 h. Four major themes are identified and presented
as a process, with each stage influencing the subsequent
one (Fig. 1), in line with the research questions previously
specified. The first theme represents the EU accession
process and what EU membership signified in general
terms. The second theme presents the specific effects of EU
membership on the domestic health system. In the third
theme, stakeholder attitudes towards the EU are depicted.
The final theme presents stakeholder expectations
regarding future health system Europeanisation. These
four themes are analysed using supporting evidence
from the data.
General reflections on a decade of EU membership
The general consensus is that the net effect of EU member-
ship has been ‘definitely’ (#25 politician) and ‘undoubtedly’
(#27 MoH public officer) beneficial, as illustrated through
the following quote.
‘Today’s citizen is more empowered; today’s citizen has
more rights; today’s citizen in Malta benefits from
much higher standards than he did or she did ten
years ago, and that also holds in the area of health.
So, whether it is the quality of the pharmaceuticals,
the cross-border directive or freedom of movement and
the level of specialization of the professionals who take
care of the patients… I think there have been huge
strides forward!’ (#18 politician)
For public officers, the following important positive
developments in the policy-making process are attrib-
uted to EU integration: a greater degree of transparency,
a more structured consultation process, enhanced inter-
sectoral cooperation and the requirement to consider
the budgetary impact of the policies. Target setting is
believed to have become more common, with an en-
hanced degree of accountability and a ‘better sense of
discipline’ (#27 MoH public officer) also characterising
the policy-making process.
The majority of interviewees believe that the obliga-
tion to comply with EU rules was important for certain
sectors in Malta to ‘evolve’ (#7 MoH public officer).
Stakeholders describe EU membership as ‘being part of a
family’ (#3 politician) or ‘a community which has its eyes
Fig. 1 The process of health system Europeanisation in the Maltese health system
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on us’ (#1 academic). This external scrutiny is deemed
important to introduce norms and appropriate behav-
iour for policy makers. This benefit of having ‘checks
and balances’ (#3 politician) in the policy-making
process is described as a significant impact of Malta’s EU
membership.
‘Securing independence is one thing, but setting up the
institutions, introducing checks and balances is most
essential and I think, perhaps, this is the gift of the
European Union to us’ (#4 clinician).
The external pressure brought to bear by the EU assisted
politicians to overcome barriers and ‘face politically difficult
decisions’ (#18 politician), often forcing them to do things
they would not have done because of competing priorities.
The accession process is described as a ‘golden period’ (#1
academic) and a ‘catalyst’ (#29 MoH public officer), bringing
about rapid changes and the establishment of standards.
‘What the European Union has helped us to do is to
actually achieve a lot in a very short period of time,
and thankfully, it was that way because otherwise we
would probably have not succeeded’ (#11 civil society).
However, the accession process also brought enormous
challenges for the small administration, and a public officer
described the situation as, ‘really swimming against the
current’ (#13 MoH public officer). A lack of capacity to meet
EU requirements (or norms) and the administrative burden
associated with excessive bureaucracy are two main chal-
lenges that most interviewees identified. The administrative
burden is the ‘price to pay’ (#18 politician) for becoming a
member of the EU and a key challenge is the shock of
having to adapt from being an organisation with an absent
documentation culture to becoming part of a system in
which documentation plays a key role. This increased
workload and burden associated with answering ques-
tionnaires or attending meetings is negatively perceived
as taking up valuable time that could be better spent
working on the core public health business. This lack
of capacity to keep up with EU demands also affects
civil society.
‘It is hard to keep up with the changes because when you
feel that you have come home with the transposition of
one EU directive, there will be other directives in the
making, opinions, positions, green papers, papers of all
the colours under the rainbow’ (#15 civil society).
Effect of EU membership on the domestic health system
The reform of the pharmaceutical sector and the develop-
ment of regulations for specialist health care professional
qualifications are believed to be the most important health
system domains that were transformed as a result of EU
membership. EU membership provided an opportunity to
overhaul and modernise the legislative framework for
public health regulation, including communicable disease
control, food safety and environmental health, which were
all significantly strengthened through institution building.
These sectors are all subject to comprehensive legislation
at the EU level that had to be transposed and imple-
mented in the domestic health system.
‘There are three or four sectors which were completely
revolutionised since we joined [the EU] medicines,
healthcare professionals or rather how they are
regulated, food safety, public health issues…’ (#10
MoH public officer).
Some stakeholders point out the important impact on
specific services and mentioned ‘cancer screening services’
(#21 MoH public officer) and ‘major, major improvement in
the blood transfusion services’ (#20 civil society). These areas
were also the subject of an EU recommendation and direct-
ive, respectively. However, stakeholders have mixed feelings
about the effectiveness of non-binding recommendations as
effective mechanisms for implementing change because–in
the area of patient safety–insufficient improvement is con-
sidered to have occurred. In line with this observation,
whilst interviewees hold divergent views regarding the
extent to which EU integration affected the actual organisa-
tion of health services, the overall perception is that health
system financing and delivery has mostly been unaffected.
‘I don’t’ think it has made much of a difference
really. Healthcare as such hasn’t changed-the
actual provision of healthcare, the quality, the
timing or the delivery of the service–I think all
that hasn’t changed at all’ (#23 clinician).
The lack of a legislative EU obligation in certain health
services is considered a missed opportunity for introducing
a much-needed reform. In primary care, no significant re-
forms were implemented other than the specialist training
programmes for general practitioners, which is a mandatory
EU requirement. An ambitious reform proposal for primary
care failed after encountering stiff stakeholder resistance.
For some interviewees, this reform failure in primary care
is partly attributed to the lack of an EU-driven obligation.
‘I think if there was some sort of directive, or
recommendation, or opinion, or strong push from
Europe, it would help us to push things forward in
primary care’ (#2 MoH public officer).
However, public officers do not view the EU influence
as being limited to areas in which a legislative obligation
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exists. They perceive a more indirect and ubiquitous
influence on various aspects of the health policy-making
process itself, with the formulation of public health strat-
egies in areas such as sexual health and non- communic-
able diseases being attributed to indirect influence of the
EU. The number of health strategies launched is re-
ported to have increased markedly following EU mem-
bership.4 Public officers feel that they were ‘pushed’ (#17
MoH public officer) by the EU to develop a national
health strategy. They describe how the need for such a
strategy has long been identified by the public health
community but was only accepted as a priority by the
political class when it became a conditionality to access
European funding.5 Other specific benefits for the health
system resulted from the use of EU funds. Constructing
and equipping an oncology hospital and the training and
development of health professionals are important ex-
amples of health system development and service trans-
formations that were made possible through EU funding.
Not all effects of the EU on the domestic health
system are positively regarded. Compliance with the
working time directive is a major health system chal-
lenge through which stakeholders believe that the EU
demonstrates a lack of understanding of the specific-
ities associated with running a small health system.
Participants expressed their concern that removing
the opt-out clause that allows workers to exceed 48 h
weekly would mean that ‘health services would col-
lapse’ (#20 civil society).
A second major health system challenge identified
refers to the reform of the pharmaceutical sector.
Although interviewees acknowledge the benefits of
increased consumer protection as a result of the im-
plementation of EU law on the quality, safety and effi-
cacy of medicines, they describe serious concerns
about the decrease in the availability of medicines in
the market and price increases following EU accession.
Stakeholders question whether the regulatory regime
adopted was ‘too draconian’ (#18 politician) for such a
small health system and whether a more efficient sys-
tem could have been considered.
Stakeholders expressed mixed views about the cross-
border directive. Although it is too early to judge the
overall effect, some believe that the directive has un-
realistically raised patients’ expectations, thereby posing
a potentially serious challenge for the health system.
Others play down its significance.
A public officer knowledgeable about the EU fiscal
governance regime registered her grave concern about
the increased EU focus on the financial sustainability
of health systems. She questioned whether domestic
policy makers would be able to continue to resist pres-
sures to implement changes to the health services sys-
tem provided free of charge at the point of use.
‘From the financial point of view, from the
budgetary point of view, the EU is focusing more on
the sustainability of our health system, and I think
that will be the major challenge in the years to
come’ (#33 EU Affairs public officer).
During the first decade of EU membership, the Maltese
health system has undergone several changes through an
array of EU mechanisms. Public health and those sectors
for which the EU has legislative competence through its
internal market legislation were particularly affected. How-
ever, core health system elements, including the financing
and organising of services, remained largely unchanged
(Tables 3 and 4).
A minority of stakeholders are of the opinion that the
changes observed in the Maltese health system would
have happened anyway, but that EU integration hastened
the implementation of the reforms. A small number of
stakeholders questioned whether the role of the EU in
influencing health system development is overstated and
suggested alternative explanations, such as national pol-
itical priorities, globalisation, a neoliberal agenda, access
to information from the Internet and the role of the
World Health Organisation, as other important drivers
for health system reform.
Domestic health system stakeholder attitudes towards EU
integration
A range of domestic health system attitudes towards EU
integration are identified with the overall perception
being a positive one despite the burden connected with a
disproportionate bureaucracy on the small administration.
‘Thank God that there is an obligation, so thank God
for the EU!’ (#21 EU affairs public officer).
This extract captures the sense of gratitude that several
stakeholders associate with EU integration. Positive atti-
tudes towards EU integration stem from various perceived
benefits. Access to knowledge and information obtained
from other MSs, which avoids the need to ‘reinvent the
wheel’ (#1 academic) and the concept of ‘riding the EU
bandwagon’ (#7 MoH health public officer) in carrying out
joint assessment work in medicines are important examples
of mechanisms that alleviate the administrative burden.
Capacity building and European peer networking are
viewed as instrumental to overcoming the loneliness and
professional isolation associated with working in policy and
regulation in a small island. EU membership has facilitated
international networking at the clinical level, which indir-
ectly serves to raise healthcare standards and improve mor-
ale and self-confidence amongst clinicians. Networking is
also described by civil society representatives seeking to
promote their members’ interests at the EU level as having
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increased in importance. In addition to networking, the im-
portance of access to technical assistance and specialised
expertise is highly valued. The European Centre for Disease
Control (ECDC) is an important source of support for the
domestic public health workforce.
‘ECDC has given us very important support. For
example, it brings a group of experts together and they
develop guidelines. So, for us, that is very good because we
don’t have such a wide pool of expertise. We have 24-
hour communication with ECDC and it is not the first
time that they carried out assessments, even specifically
for us. Last year we had Q fever. It was the first case that
we actually came across in the last few years and we
wanted guidance. ECDC actually carried out an
assessment for us. We have reassurance that we have
someone to turn to’ (#6 MoH public officer).
However, despite these positive examples, several
stakeholders believe that ‘The approach of the EU to
Table 3 Health system transformation and adaptation (Malta 2004–2014)
Health system change
Description Europeanisation Mechanisms Analysis
Public health policies
and strategies
Transformation Non-binding EU communications, strategies,
reports
Participation in EU working groups
Domestic health policy-making process
underwent significant change and a
number of important health strategies
were developed
Cancer Transformation Non-binding EU Council Recommendation on
Cancer Screening EU Funds for hospital, equipment
and capacity building
Participation in EU Joint Actions and networks
Submission of health information statistics
Services in the area of cancer have been
transformed through the development of
a national plan, cancer screening services,
training of health professionals and the
constructions of a new oncology hospital
Development of specialist
training programmes for
doctors
Transformation DirectiveEU funds for capacity building Transposition of legislation and establishment
of medical specialist registers as well as
structured post graduate training programmes
Regulation of quality, safety
and efficacy of medicines
Transformation Directives EU funds for capacity building
Participation in networks and working groups
Transposition of legislation and setting up of
the competent authority to regulate the
placing of medicines on the market
Establishment of regulatory
institutions with separation of
regulatory and provider roles
Adaptation Directives Participation in networks and
working groups
Transposition of legislation and setting up of
competent authorities for licensing providers
and regulating public health standards
Health statistics Adaptation Participation in networks and working groups
Benchmarking
(EUROSTAT regulations recently entered into force)
A good health information system was already
in place prior to accession but EU legislation,
policy and networking helped to strengthen it
Table 4 Inertia and resistance to health system reform (Malta 2004–2014)
Health system continuity
Description Europeanisation Mechanism Analysis
Primary care Inertia Directive (on training of general
practitioners)
The necessary changes were implemented to the
specialist training for general practitioners but
otherwise no significant changes were reported
and the planned 2009 reform was not implemented
Patient safety Inertia Non-binding EU Council Recommendation
on Patient Safety
Reports on the implementation of patient safety
indicate that the Maltese health system has not made
any significant advances on this aspect
Cross border care Inertia Directive Transposition of minimal requirements of the directive
Pricing and reimbursement Inertia Directive Minimum requirements of the transparency directive
on medicines were transposed but no major changes
to the system of pricing or reimbursement were
implemented
Working time Retrenchment Directive Extensive use of the ‘opt-out’ clause for doctors
agreeing to work more than 48 h weekly so as to
avoid major changes to the system
Funding of public
health care
Retrenchment Country specific recommendations emerging
from EU fiscal and economic governance
mechanisms
Despite health system sustainability being repeatedly
mentioned in several annual reports the model of
health financing has been strongly protected by
successive Governments
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health …is disappointing’ (#6 MoH public officer). Disap-
pointment is a result of the lack of priority accorded to
health at the EU level. Health ministers are viewed as
being weak in relation to their finance counterparts.
Poor budgetary allocations and the limited power of the
Commission Directorate General responsible for health
are viewed as resulting in a weak stand when confront-
ing multi-national lobbies. The tobacco and food indus-
tries raise a particular concern. Another key source of
disappointment is the ‘one size fits all’ approach, which
belies a lack of understanding of the specific challenges
faced by MSs given their geo-demographic or socio-
economic profiles.
‘Most of the people who are taking the decisions in
Brussels come from large countries and they may not
perceive what our problems are. For example, one
maternal death is sufficient to screw up your data…’
(#26 clinician).
Specifically, public officers and academics expressed
their disappointment and frustration at being unable to
tap into EU funds to develop local research capacity,
with EU funds invariably going to centres in larger
countries in which cutting-edge research is taking
place. A politician who expressed his belief that ‘there
are funds provided you apply in a diligent way and
abide by the rules’ (#19 politician) dissented starkly
from the general consensus. The co-funding element,
lack of capacity and administrative bureaucracy are all
listed as key barriers to accessing EU research funds.
Small states’ particular needs are also believed to be
often overlooked in impact assessments. Whilst a couple of
initiatives to lighten the burden exist in the pharmaceutical
sector, they are deemed to fall far short of addressing small
state specificities and are viewed as providing an excep-
tional ‘way out instead of having an infrastructure
which is friendly to small member states’ (#31 EU
affairs public officer).
An interviewee with extensive experience in technical
meetings uniquely stated that his requests about small
size issues ‘are typically then taken on board, although to
varying extents’ (#17 MoH public officer), thereby illus-
trating the importance of intervening early in the initial
technical stages to maximise influence.
Disappointment is also related to a series of unmet ex-
pectations, foremost amongst which is the lack of EU
engagement and support related to the problems posed
by immigration.
‘The biggest disappointment, not just in healthcare but
for the whole Maltese population although it also is
important for healthcare, is the failure of the EU to
engage with immigration’ (#4 clinician).
The gap between rhetoric and documentation produced
at the EU level and tangible change at the operational
level, lack of continuity between EU Presidencies and in-
ability to ensure effective enforcement are other examples
of work being carried out at the EU level but that is not
making the desired impact at the domestic level.
‘Decisions are taken at the very top by the ministers
but the problem mainly is whether they seep down
and are actually implemented at the operational level.
There is a huge gap’ (#30 MoH public officer).
Amongst some public servants, disappointment associ-
ated with unmet expectations coupled with fatigue from
the struggle to cope with daily EU pressures appears to
be leading to Euroscepticism.
Expectations regarding future health system
Europeanisation
The role that the EU should play in public health policy
and health systems is contentious. Some stakeholders
state that ‘people want subsidiarity to stay, they want to
run their own system’ (#20 civil society), whereas others
express a desire for a greater degree of EU involvement.
Even those participants who agree with a greater role for
the EU acknowledge the sensitivity that exists around
the principle of subsidiarity and the problem of the
existing diversity of European health systems that pre-
vent the EU from assuming a larger role.
‘Let’s imagine that reforms in primary healthcare will
be driven at the EU level across Europe, let’s dream
about that! But then again you cannot really have the
‘one size fits all’ because that would result in chaos
because really, you can’t standardize practices like
that’ (#1 academic).
Growing Euroscepticism and the increasing fiscal and
economic orientation being taken by EU institutions are
believed to be contributing to heightened tension between
Europeanists and pro-autonomy forces.
‘There are two schools of thought, those who think that
the European Union should exercise greater control
possibly from Brussels versus those who want more
space for Member States to decide for themselves.
Although these divisions have always existed in the
European Union, I think that they will now become
more prevalent’ (#24 MoH public officer).
The following phrase captures the general feeling
amongst most interviewees: ‘it would be more beneficial
that Member States are actually doing more together rather
than the opposite’ (#8 EU Affairs public officer). Several
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policy areas in which a greater role for the EU is
deemed both desirable and feasible are identified. Foremost
amongst these areas is the issue of access to affordable
medicines. Since the financial crisis, the issue of affordabil-
ity of medicines and attention to pricing has been noted to
be no longer only of concern to small or poor countries but
also has affected MSs, which was hitherto unaffected by it.
Action at the EU level can counteract the limitations asso-
ciated with a small market size.
‘Most Member States are now facing sustainability
and pricing issues, so I guess, the EU through better
cooperation, could help them face these challenges
jointly’ (#31 EU affairs public officer).
Several interviewees feel that the EU should play a more
active role in the prevention and control of non-
communicable disease, with obesity, diabetes and tobacco
control considered as key priorities.
‘If I had to pinpoint one area where the EU could
come together more effectively is in the major non-
communicable diseases to make sure that what is being
done at national level in twenty-eight different countries,
is shared, brought together and supplemented at EU level
to make sure that we get the best results faster and
translated into more effective remedies that can be
shared by all patients affected across the EU’ (#18
politician).
The introduction of a basic level of care and a stand-
ard health care package across the EU, as well as stan-
dards for primary care, are considered important future
developments for EU health policy by domestic stake-
holders. The adoption of minimum standards of training
and qualifications for specialist nurses, for allied health
care professionals and for carers is considered a priority.
A few interviewees expressed their desire for the EU to
play a larger role in quality and patient safety. Some in-
terviewees see the need for the EU to take a more active
role in developing health information systems. Voluntary
mechanisms, such as using enhanced cooperation proce-
dures, are proposed as methods to implement such mea-
sures to ensure flexibility and avoid the much maligned
‘one size fits all’ approach.
In keeping with the general desire for the EU to play a
larger and more visible role, most interviewees do not
believe that excessive involvement or undue influence of
the EU exists on the Maltese health system. The notable
exception is the perceived EU influence on curbing
public health care expenditures, which is unequivocally
deemed as a threat by all stakeholder groups. The EU’s
pressure to curb health sector expenditures is believed
to reflect an insufficient understanding of the domestic
health system context and that negative consequences
for the health system could result from such approaches.
A public officer strongly expressed his view that it is
very important to defend the principle of retention of a
health service that is free of charge at the point of use.
‘My feeling was that the Commission was trying to
exert a bit too much influence and the worst thing
about it was that the people making those suggestions
or making those statements were coming from
economical background. So, if I may daresay, their
recommendation does not only belie certain ignorance
of the local context, but also of basic public healthcare
principles’ (#17 MoH public officer).
Although some clinicians feel that the EU should play a
role in setting down basic care standards, others hold that
this role should remain within the remit of scientific bodies
and that European institutions should not attempt to re-
place scientific guidelines with bureaucratic ones. Regarding
human resource planning and deployment, public officers
and civil society representatives hold divergent views on the
extent to which national control on decision making should
be retained; however, one participant described mandatory
staff patient ratios at the EU level as a ‘no-go situation’ (#13
MoH public officer).
Interviewees recognise the need for the EU to coordin-
ate between the different MSs and acknowledge the sup-
port provided, particularly by ECDC in the area of
communicable disease control. However, a detailed ap-
proach should be elaborated on at the MS level and the
EU should refrain from taking up roles that are already
suitably catered for by other organisations, such as the
World Health Organisation (WHO).
‘I think that the Commission is there to coordinate
what happens across EU but then it is up to
individual Member States to manage their response
because each Member State has different capacities,
different limitations and different cultures’ (#6 MoH
official).
Finally, religiously inspired values, including issues con-
cerning reproductive health and abortion in particular, are
an important unique theme for Maltese stakeholders. Any
attempt by the EU to set policy would be strongly resisted.
Discussion
Summary of key findings
Figure 1 illustrates how the process of health system
Europeanisation is perceived to have occurred in Malta.
The accession process provided a unique opportunity
for health system reform, particularly in the area of med-
icines and professional training. However, other aspects
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of the health system, including the mechanisms of financing
and delivery, were unaffected. Stakeholders positively view
the EU as offering important support through technical
and financial assistance and capacity building as well as in
overcoming local sources of resistance to change. Negative
attitudes are associated with administrative burdens and
conflicting values. Overall, domestic stakeholders in the
Maltese health system are positive over the EU influence
on their health system and desire greater EU involvement
in health policy as long as the influence is flexible enough
to take into account small state specificities.
Health system Europeanisation in practice
Tables 3 and 4 show how the degree of Europeanisation
within the Maltese health system has varied amongst the
different health system domains. Where Europeanisation
has occurred, it has been done through diverse mecha-
nisms–confirming that both regulatory compliance and
social learning play a role in the Europeanisation process
[44]. The window of opportunity to implement reforms
provided by the EU accession process and described in
this study confirms the findings from the literature in
other sectors [48–50]. The highest adaptation pressures
were experienced in the pharmaceutical sector and mu-
tual recognition of professional qualifications, including
medical specialist training. This finding is not surprising
given that the principle of free movement underpinning
these sectors is a foundational EU policy [51–53] and
both areas were highlighted as being impacted in pre-
accession assessments of candidate countries [54], in-
cluding Malta [55, 56]. The impact on the pharmaceut-
ical sector in Malta was also previously described [57].
Malta did not experience public health reforms associ-
ated with accession on the same scale as that reported in
other countries [58], and the health services’ core ele-
ments appear to have remained mostly unaffected. For
some stakeholders, this phenomenon represented a
missed opportunity to bring about change and is most
evident in the area of primary care. In primary care, a
series of proposals for reform failed to materialise [59],
and stakeholders appear to believe that an EU obligation
would most likely have provided the necessary impetus
for reforms to be implemented.
Therefore, this study established that, to date, the
dominant focus for health services organisation and de-
livery resides at the national level. However, Hervey’s ob-
servation that the influence of the EU permeates
‘virtually every aspect of such [health] policies’ [5] also
receives support from our findings because the EU ap-
pears to be exerting an indirect effect on health policy
making by stimulating the production of several national
health strategies.
A manifest implementation gap between what is de-
cided at the EU level and the effect within the health
system emerged as an important critique of the effective-
ness of Europeanisation in practice. This consideration
is important because health policy is governed to a large
extent through soft law, which–although considered to
play an important role [27, 60]–our findings indicate has
mixed effects. For example, stakeholders describe the
implementation of the recommendation on cancer screen-
ing as a success but the implementation of the recommen-
dation on patient safety as poor. The effectiveness of
implementation has been found to vary among countries
[61], and small states must often prioritise because of their
limited capacity [62, 63]. In these circumstances is it not
surprising that non-mandatory initiatives assume a lower
priority. Furthermore, the existence of strong veto players
is likely to affect the ability of governments to implement
non-binding recommendations.
A small state perspective on health system
Europeanisation
A survey of European health stakeholders found mixed
perceptions of whether or not role expansion should
occur for the EU in health policy [6]. A study carried
out in the United Kingdom on the balance of compe-
tence between the EU and MSs in the field of health pol-
icy concluded that the balance is ‘broadly right’ [64].
Stakeholders from our study in the Maltese setting dem-
onstrate support for further EU involvement in certain
areas in which action at the level of a small state is
deemed insufficient to achieve the desirable public
health results. Therefore, the expansionist stakeholder
attitudes towards future EU health policy observed in
this study can partly be explained as being a result of the
special characteristics of small states. Small states benefit
disproportionately from the existence of effective regional
organisations [65] and ‘soft’ security aspects, including
public health, have been described amongst such benefits
[66]. For example, the literature on the value of ECDC is
mixed. Some hail this institution as a policy success [6],
whereas others question its ability to fulfil its mission
because of its heavy reliance on country experts [7, 67].
Our study found that Maltese health system stakeholders
are strongly positive about the role played by the ECDC.
Therefore, discussions on the future role for ECDC should
also consider the benefits that accrue to small MSs.
Networking as a means of overcoming professional iso-
lation emerged as a substantial benefit for domestic
stakeholders. Furthermore, the emerging global inter-
dependence of public health [68] makes it even more
pressing for small states to acquire the protection and
shelter of a regional organisation to defend public
health interests [66]. This study revealed a desire for
the EU to play a larger role in ensuring access to af-
fordable medicines, a key issue for the small domestic
market. The Joint Procurement Agreement on medical
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countermeasures for cross border health threats [69] and
the setting up of an expert working group on safe and
timely access to medicines [70] are examples of policy ini-
tiatives that have been championed by small states.
However, the desire for a larger EU role in health sys-
tems is offset by stakeholder disappointment with the
lack of understanding of specificities related to the geo-
demographic profile of Malta. Although the literature
has traditionally portrayed the Commission as being an
ally for small states [62, 71], our study found that this
portrayal is not always the case. A potential explanation
is that many key decision makers in EU institutions hail
from larger countries. The ‘one size fits all’ approach ap-
pears to have created problems in the implementation of
the working time directive, aspects of the pharmaceut-
ical Acquis [72] and in access to research funding. The
lack of public health research in small states has been
described elsewhere [73–76] and the findings from this
study serve to confirm that this lack of research remains
a particular challenge for small states.
Critique of Europeanisation theory
The typical dilemma of establishing causality in
Europeanisation research emerges in this study [77].
One may question whether the role of EU integration as
a catalyst for reform is overstated and whether change
could equally have resulted from other influences [78].
The broad consensus amongst stakeholders interviewed
is that beyond the necessity of regulatory compliance–
markedly associated with the accession process–the overall
on-going change attributed to EU influence within the
health system is brought about primarily through network-
ing. This consensus concurs with the concept of socialisa-
tion and social learning as vehicles for Europeanisation as
described in the social constructivist model [29, 44]. In
these circumstances in which no EU regulation or directive
exists as a point of reference, it becomes far more difficult
to determine how much of the observed change is driven
by the EU as opposed to other forces resulting from eco-
nomic globalisation or neoliberalism.
Strengths and limitations
This study is innovative and attempts to cover a broad
scope. Efforts were undertaken to ensure reflexivity through
the research process [47]. The core research team consisted
of three individuals, two PhD students with previous public
health research experience and one post-doc researcher
with public health practice and experience in qualitative re-
search methodologies. The principal investigator is based in
the Maltese health system and the collaborating researchers
are in The Netherlands. Their different locations allowed
in-depth contextual knowledge to be complemented by ex-
ternal assessment and provided a forum for reflecting on
the study design and analysis, and to critically question the
process at all stages. The principal investigator previously
occupied senior positions within the Ministry of Health in
Malta, including responsibility for European and inter-
national affairs. The motivation for this research stemmed
from an interest in investigating the impact of EU member-
ship on the health system in Malta. All participants were re-
cruited through the professional network of the principal
investigator who did not share her own opinion until the
interview was complete, even when this opinion was re-
quested by the interviewee because the perception of the
interviewee was the main focus of the interview [79]. Des-
pite all of the steps taken to assure quality, this study has
certain limitations. This study provides a picture of the situ-
ation through the lens of domestic stakeholders at a single
point in time and focuses particularly on a number of issues
related to Malta. Thus, the findings may not necessarily
transfer to other contexts, and further research is necessary
to determine whether other small countries face similar
challenges. Additionally, complementary approaches using
different techniques, such as process tracing, may be per-
formed in the future to validate the findings and to strive to
overcome the limitations previously described in establish-
ing causality. Nevertheless, this study contributes important
innovative perspectives on European health policy, and
further research amongst domestic stakeholders in other
Member States is recommended.
Conclusions
Establishing causality is a dilemma for researchers in the
field of Europeanisation. Yet, the findings from this
study appear sufficiently strong to indicate that domestic
stakeholders believe that Malta’s integration into the EU
provided an external drive for certain reforms to be im-
plemented. Public health policies appear to be affected
more by EU policy than health care services. A policy in-
frastructure that is ‘friendly’ to small Member States is
deemed preferable to the creation of specific exceptions.
We found evidence of both ‘passive downloading’ of EU
regulations and ‘active usage’ of EU rules to promote the
desired norms and objectives. Although the health sector
is a peripheral policy area for the EU, merit exists in
using Europeanisation as a concept to better understand
the evolution of this policy area in the EU. Obtaining a
deeper understanding of the interaction between the EU
institutions and MSs and the tension between, on the
one hand, the desire for a larger EU mandate and, on
the other hand, the safeguarding of subsidiarity is crit-
ical. This understanding is particularly relevant in view
of the current context in which health systems are being
increasingly framed in terms of financial and economic
considerations with the potential marginalisation of
public health from the policy objectives at the EU level.
We conclude that domestic health system actors in
Malta generally share a positive assessment of the overall
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impact of EU membership on the health system and
support a larger role for the EU in several policy areas.
This support is generated from positive experiences,
from a sense of disappointment that not enough is being
done at the EU level to promote public health and from
a desire that the EU provides support to overcome do-
mestic health system problems linked to small market
size. At the EU level, the financial crisis and ensuing
effects on several health systems may provide an import-
ant opportunity to alter the propensity of at least some
Member States to engage in more intensive health sys-
tem cooperation. This study, by providing a small state
perspective to health system Europeanisation, challenges
the traditional narrative that Member States do not see a
need for deeper integration in the field of health policy.
What would be interesting to establish in this context is
whether this need for deeper integration is felt by all
states or whether it is felt more intensely by smaller
states that lack sufficient resources, knowledge and pol-
icy initiatives but benefit from uploading their problems
to the EU level or finding additional resources that they
individually lack. Therefore, this study sets the scene for
broadening the analysis to other small states to ascertain
whether our findings are uniquely applicable to Malta or
to small EU member states in general. However, other
interesting possibilities exist that arise from our study,
including the question: do larger states face similar chal-
lenges and dilemmas in their health systems at regional
and local levels and would our findings and arguments
apply equally to them?
Endnotes
1The European Semester is an EU-level policy co-
ordination tool that contributes towards the broader
EU aims of strengthening economic governance and
greater policy co-ordination. This tool provides a more
integrated surveillance framework for the implementa-
tion of fiscal policies under the Stability and Growth
Pact, and the implementation of structural reforms
through national reform programmes. The Commis-
sion publishes Country-Specific Recommendations for
each Member State on the basis of a thorough assess-
ment of every Member State’s plans for sound public
finances and policy measures to increase growth and
jobs. For further information, the reader is referred to http://
ec.europa.eu/europe2020/making-it-happen/index_en.htm
[accessed on 6 September 2015]
2For a comprehensive yet simple introduction to
Europeanisation theories, the reader is referred to
Harwood Mark, Chapter 3 Europeanisation in Malta
in the European Union Ashgate Publishing 2014.
3English is an official language in the Republic of
Malta.
4The main health strategies published during the
period following accession are listed in Chapter 6 of
the Health Care Systems in Transition Report for
Malta, which is available at http://www.euro.who.int/
en/about-us/partners/observatory/publications/health-
system-reviews-hits/full-list-of-country-hits/malta-hit-
2014 [accessed on 09/10/15].
5The European Commission issued guidance on a
number of conditionalities that need to be fulfilled for
access to the European Structural and Investment Funds
2014–2020. In the area of health, the existence of a strategic
plan for the health system is one such criterion. Further in-
formation is available at http://ec.europa.eu/regional_policy/
index.cfm/en/information/legislation/guidance/ [accessed on
6 September 2015].
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